Publications by authors named "Mark Malkin"

Claim this Profile
P
Phase 2 Study of Sorafenib, Valproic Acid, and Sildenafil in the Treatment of Recurrent High-Grade Glioma.
Andrew S Poklepovic, Palak Shah, Mary Beth Tombes, Ellen Shrader, Dipankar Bandyopadhyay, Mark G Malkin

medRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-Based Prognostication: Neuro-Oncology.
Kristin A Waite, Gino Cioffi, Mark G Malkin, Jill S Barnholtz-Sloan

Semin Neurol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
tRNA Function and Dysregulation in Cancer.
Tania Gupta, Mark G Malkin, Suyun Huang

Front Cell Dev Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing cancer and living meaningfully (CALM) in adults with malignant glioma: a proof-of-concept phase IIa trial.
Ashlee R Loughan, Kelcie D Willis, Sarah Ellen Braun, Gary Rodin, Autumn Lanoye, Mark Malkin

J Neurooncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Working memory training for adult glioma patients: a proof-of-concept study.
Sarah Ellen Braun, Farah J Aslanzadeh, Autumn Lanoye, Stephanie Fountain-Zaragoza, Mark G Malkin

J Neurooncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma.
Danielle Shafer, Mary Beth Tombes, Ellen Shrader, Alison Ryan, Dipankar Bandyopadhyay, Mark Malkin

Neurooncol Adv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis.
Iyad Alnahhas, Mohammad Jawish, Mouaz Alsawas, Alicia Zukas, Larry Prokop, Mark Malkin

Clin Lymphoma Myeloma Leuk· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Primary Central Nervous System Posttransplant Lymphoproliferative Disorder in an Adult Kidney Transplant Recipient: A Case Report.
Mashya Abbassi, Roger Riley, Mark Malkin, Yang Tang, Bipin Rajendran

Exp Clin Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Review and Neuropsychological Case Study.
Ashlee R Loughan, Aislyn Allen, Robert Perna, Mark G Malkin

Clin Neuropsychol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing Tecfidera for cancer.
Laurence Booth, Mark Malkin, Paul Dent

Aging (Albany NY)· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
Iyad Alnahhas, Mark Malkin

Neurology· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of plasma exchange in Hashimoto's encephalopathy: A case report and review of the literature.
Melissa K Cook, Mark Malkin, Matthew S Karafin

J Clin Apher· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma.
Peter S LaViolette, Nikolai J Mickevicius, Elizabeth J Cochran, Scott D Rand, Jennifer Connelly, Mark G Malkin

Neuro Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics.
Maxime S Heroux, Marla A Chesnik, Brian D Halligan, Mona Al-Gizawiy, Jennifer M Connelly, Mark G Malkin

Physiol Genomics· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.
Kathleen M Schmainda, Melissa Prah, Jennifer Connelly, Scott D Rand, Raymond G Hoffman, Mark G Malkin

Neuro Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.
Jane L Roberts, Laurence Booth, Adam Conley, Nichola Cruickshanks, Mark Malkin

Cancer Biol Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of perfusion on diffusion changes in human brain tumors.
Alexander D Cohen, Peter S LaViolette, Melissa Prah, Jennifer Connelly, Mark G Malkin

J Magn Reson Imaging· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.
Peter S LaViolette, Alex D Cohen, Melissa A Prah, Scott D Rand, Jennifer Connelly, Mark G Malkin

Neuro Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
Roger Stupp, Eric T Wong, Andrew A Kanner, David Steinberg, Herbert Engelhard, Mark Malkin

Eur J Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.
Phioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, Jan Drappatz, H Ian Robins, Mark G Malkin

Int J Radiat Oncol Biol Phys· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI.
Benjamin M Ellingson, Peter S LaViolette, Scott D Rand, Mark G Malkin, Jennifer M Connelly

Magn Reson Med· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas.
Benjamin M Ellingson, Mark G Malkin, Scott D Rand, Pete S LaViolette, Jennifer M Connelly

J Neurooncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri.
Benjamin M Ellingson, Scott D Rand, Mark G Malkin, Kathleen M Schmainda

J Neurooncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity.
Benjamin M Ellingson, Mark G Malkin, Scott D Rand, Jennifer M Connelly, Carolyn Quinsey

J Magn Reson Imaging· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental risk factors for brain tumors.
Jennifer M Connelly, Mark G Malkin

Curr Neurol Neurosci Rep· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis